Quoin pharmaceuticals to announce first quarter 2024 financial results on may 9, 2024

Ashburn, va., may 02, 2024 (globe newswire) -- quoin pharmaceuticals ltd. (nasdaq: qnrx) (the “company” or “quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the company plans to release its first quarter 2024 financial results before the market opens on thursday, may 9, 2024.
QNRX Ratings Summary
QNRX Quant Ranking